Using Artificial Intelligence to revolutionise drug discovery and development

Описание: BenevolentTech is developing an advanced artificial intelligence platform that helps scientists make new discoveries and redefines how scientists gain access to, and use, all the data available to them to drive innovation. The technology is built upon a deep judgement system that learns and reasons from the interaction between human judgement and data. Jackie Hunter, CEO of BenevolentAI discusses the potential of artificial intelligence to advance drug developement, with Adrian Dawkes of PharmaVentures